Lepore A, Lucarini N, Evangelista M A, Palombaro G, Londrillo A, Ballarini P, Borgiani P, Gloria-Bottini F, Bottini E
Center of Hygiene and Preventive Medicine, U.L.S.S., Penne, Italy.
J Perinat Med. 1989;17(3):195-201. doi: 10.1515/jpme.1989.17.3.195.
A sample of children treated by phototherapy during the neonatal period has been studied in the population of Penne (South Eastern Italy) in order to confirm the association previously reported in newborns from the population of Rome between neonatal jaundice and phenotypes of adenosine deaminase (ADA) and acid phosphatase (ACP1). The present data confirm that the incidence of clinically relevant jaundice is much greater in newborns of phenotype ACP1 BA carrying ADA2 allele than in other infants. Since ACP1 probably acts as flavin mononucleotide phosphatase and is modulated by purine nucleotides, it is likely that enzymes of purine nucleotide metabolism (including ADA), ACP1 and flavoenzymes (including gluthatione reductase and enzymes of Krebs cycle), may represent a polygenic complex influencing bilirubin levels in the first few days of life.
为了证实先前在罗马人群新生儿中报道的新生儿黄疸与腺苷脱氨酶(ADA)和酸性磷酸酶(ACP1)表型之间的关联,对意大利东南部彭内人群中新生儿期接受光疗的一组儿童样本进行了研究。目前的数据证实,携带ADA2等位基因的ACP1 BA表型新生儿中临床相关黄疸的发生率远高于其他婴儿。由于ACP1可能作为黄素单核苷酸磷酸酶并受嘌呤核苷酸调节,嘌呤核苷酸代谢酶(包括ADA)、ACP1和黄素酶(包括谷胱甘肽还原酶和三羧酸循环酶)可能代表一个多基因复合体,在生命的最初几天影响胆红素水平。